MEI Pharma, Inc. (MEIP): Price and Financial Metrics

MEI Pharma, Inc. (MEIP): $3.37

0.12 (+3.69%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add MEIP to Watchlist
Sign Up

MEIP Price/Volume Stats

Current price $3.37 52-week high $7.97
Prev. close $3.25 52-week low $3.20
Day low $3.22 Volume 6,500
Day high $3.37 Avg. volume 23,116
50-day MA $3.95 Dividend yield N/A
200-day MA $5.73 Market Cap 22.45M

MEIP Stock Price Chart Interactive Chart >


MEI Pharma, Inc. (MEIP) Company Bio


MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company was founded in 2000 and is based in San Diego, California.


MEIP Latest News Stream


Event/Time News Detail
Loading, please wait...

MEIP Latest Social Stream


Loading social stream, please wait...

View Full MEIP Social Stream

Latest MEIP News From Around the Web

Below are the latest news stories about MEI PHARMA INC that investors may wish to consider to help them evaluate MEIP as an investment opportunity.

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

SAN DIEGO, December 11, 2023--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced clinical data from the monotherapy dose escalation stage of the ongoing Phase 1 study evaluating voruciclib, a selective oral cyclin-dependent kinase 9 ("CDK9") inhibitor, alone and in combination with venetoclax (Venclexta®), a B-cell lymphoma 2 ("BCL2") inhibitor, in p

Yahoo | December 11, 2023

11 Cheapest Stocks With Biggest Upside

In this piece, we will take a look at the 11 cheapest stocks with the biggest upside. If you want to skip our introduction to stock valuation and recent market news, then take a look at 5 Cheapest Stocks With Biggest Upside. Identifying the right stocks to invest in is a science that involves evaluating […]

Yahoo | November 27, 2023

AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer

AstraZeneca's (AZN) capivasertib gets approval in combination with Faslodex for HR-positive, HER2-negative metastatic breast cancer.

Yahoo | November 17, 2023

Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises

Ironwood's (IRWD) third-quarter 2023 earnings miss estimates, while revenues beat the same. Linzess collaboration revenues drive the top line.

Yahoo | November 10, 2023

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

SAN DIEGO, November 09, 2023--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today reported results for the quarter ended September 30, 2023 and highlighted recent corporate events.

Yahoo | November 9, 2023

Read More 'MEIP' Stories Here

MEIP Price Returns

1-mo -12.01%
3-mo -26.90%
6-mo -52.20%
1-year -31.08%
3-year -95.13%
5-year -94.53%
YTD -41.90%
2023 19.05%
2022 -90.88%
2021 1.14%
2020 6.45%
2019 -6.06%

Continue Researching MEIP

Want to see what other sources are saying about MEI Pharma Inc's financials and stock price? Try the links below:

MEI Pharma Inc (MEIP) Stock Price | Nasdaq
MEI Pharma Inc (MEIP) Stock Quote, History and News - Yahoo Finance
MEI Pharma Inc (MEIP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!